Cancer news
Researchers use drug-radiation combo to eradicate lung cancer
Oct 29, 2009 |
5 / 5 (5) |
0
Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.
WHO study suggests link between cell phones and tumors
Oct 27, 2009 |
4.2 / 5 (23) |
17
(PhysOrg.com) -- Preliminary results of an International investigation by the World Health Organization (WHO) suggest there may be a "significantly increased risk" of some types of brain tumors after use of ...
'Cross-talk' mechanism contributes to colorectal cancer
Nov 13, 2009 |
5 / 5 (1) |
0
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have identified a molecular mechanism that allows two powerful signaling pathways to interact and begin a process leading to colorectal ...
Researchers 'notch' a victory toward new kind of cancer drug
Nov 11, 2009 |
4 / 5 (4) |
1
(PhysOrg.com) -- Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed. Their discovery, published in ...
Researchers find a weak link in cancer cell armor
Nov 11, 2009 |
5 / 5 (4) |
0
(PhysOrg.com) -- Professor Robert Weiss has found that when two particular genes are inhibited, cancer cells are destroyed at a greater rate. The study is published in the Nov. 9 issue of PNAS.
Drug shrinks lung cancer tumors in mice
Nov 10, 2009 |
4.8 / 5 (6) |
0
(PhysOrg.com) -- A potential new drug for lung cancer has eliminated tumours in 50% of mice in a new study published today in the journal Cancer Research. In the animals, the drug also stopped lung cancer ...
Hundreds of genes distinguish patients likely to survive advanced melanoma
Nov 09, 2009 |
not rated yet |
0
Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. Now it may be possible to identify ...
Possible origins of pancreatic cancer revealed
Nov 02, 2009 |
3 / 5 (1) |
0
(PhysOrg.com) -- MIT cancer biologists have identified a subpopulation of cells that can give rise to pancreatic cancer. They also found that tumors can form in other, more mature pancreatic cell types, but ...
Study uncovers key to how 'triggering event' in cancer occurs
Oct 29, 2009 |
5 / 5 (2) |
0
Researchers at the University of Michigan Comprehensive Cancer Center have discovered what leads to two genes fusing together, a phenomenon that has been shown to cause prostate cancer to develop.
HPV vaccine makes girls more cautious about sex
Oct 27, 2009 |
2.7 / 5 (3) |
0
(PhysOrg.com) -- Nearly 80% of girls say that having the HPV vaccine makes them think twice about the risks of having sex, according to a University of Manchester study published in the British Journal of ...
Alternatively spliced tissue factor identified as promising new biomarker for aggressive cancers
Oct 26, 2009 |
5 / 5 (1) |
0
A recently discovered form of the protein that triggers blood clotting may play a key role in the molecular mechanisms leading to the growth of certain metastatic cancers, according to new research reported by an international ...
Protein is linked to lung cancer development
Oct 22, 2009 |
5 / 5 (3) |
0
(PhysOrg.com) -- A protein that normally helps defend cells from infection can play a critical role in the development of lung cancer, according to MIT cancer biologists.
Study Shows How Normal Cells Influence Tumor Growth
Oct 21, 2009 |
5 / 5 (1) |
1
(PhysOrg.com) -- It was once thought that the two communities of cells within a cancerous breast tumor - fast-growing malignant cells and the normal cells that surround them - existed independently, without interaction. Then ...
Study finds way to protect healthy cells from radiation damage
Oct 21, 2009 |
5 / 5 (11) |
3
Researchers at the University of Pittsburgh School of Medicine and the National Cancer Institute (NCI), part of the National Institutes of Health, may be hot on the heels of a Holy Grail of cancer therapy: They have found ...
Revealing cancers' weak spots: Researchers exploit genetic 'co-dependence' to kill treatment-resistant tumor cells
Oct 20, 2009 |
5 / 5 (1) |
1
(PhysOrg.com) -- Cancer cells fueled by the mutant KRAS oncogene, which makes them notoriously difficult to treat, can be killed by blocking a more vulnerable genetic partner of KRAS, report scientists at ...
